ClinicalTrials.gg
RecruitingNCT06036069Updated Oct 13, 2023

Effect of Whole Body Vibration Versus Core Stability Exercises on Balance and Muscle Strength in Children With Down Syndrome

An interventional study of Conventional physical therapy in Down Syndrome, sponsored by Ragaee Saeed Mahmoud. Recruiting at 1 site in Egypt. Open to participants aged 10 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-13.

Sponsored by Ragaee Saeed Mahmoud · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 10 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
10 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Down Syndrome with a site in Egypt — 5 open to participants now, 7 under way, none of them phase 3. Down Syndrome · Egypt.

Planned enrollment
2nd of 15
60 · median 40
Started
2023
with 5 others
No phase
14 of 21
3 open now
Registered
11th of 21
by date
Lead sponsor
1 of 21
Ragaee Saeed Mahmoud

Among the 21 studies in Down Syndrome with a site in Egypt, this one is the 2nd largest by planned enrollment of the 15 interventional ones that give a count, is one of 6 that started in 2023, is one of 14 with no phase, and was the 11th registered.

Down Syndrome

439 studies on the registry are indexed under Down Syndrome; 99 are open to participants now.

Browse Down Syndrome studies →

Open to participants now

5 of the 21 studies in Down Syndrome with a site in Egypt are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 74 Down Syndrome studies recruiting now, 14 (19%) set no upper age limit and 57 (77%) stop at 75 or younger; 60 take children under 18; 19 take healthy volunteers.

This study: 10 Years to 16 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Down Syndrome with a site in Egypt, or all of them as a file.
02

Study summary

Children had Down syndrome often have impaired balance and postural control and result as less active than their peers that can lead to reduced quality of life and movement skills. Effects of physical activity may be important in preventing falling risk and health consequences in those children

Read the detailed description

Sixty children from both genders (boys and girls) participated in this study, their ages ranged from 10 to 16 years and they were randomized into three groups of same number (A, B and C). Groups (A) received conventional physical therapy program, group (B) received the same conventional physical therapy program of group (A) and core stability exercises while group (C) received the same conventional physical therapy program of group (A and B) and whole body vibration exercise

03

Conditions studied

  • Down Syndrome

Browse trials for

Keywords

  • Children; Core Stability Exercises; Down Syndrome; Whole Body Vibration
04

Who can participate

Ages eligible
10 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 10 to 16 years.
  • Able to recognize commands given to them.
  • Understand our verbal command and encouragement.
  • Stand and walk independently without repeated falling.

Exclusion criteria

Exclusion Criteria:

  • Children with any neurological (signs of epilepsy and instability of atlantoaxial joint).
  • Musculoskeletal, or mobility disorders.
  • Cardiac anomalies.
  • Vision or hearing loss.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Conventional physical therapy group

    It consisted of 20 children received conventional physical therapy

    Other: Conventional physical therapy

  • Experimental
    Core stability exercises group

    It consisted of 20 children received conventional physical therapy and core stability exercises

    Other: Conventional physical therapy

  • Experimental
    Whole body vibration

    It consisted of 20 children received conventional physical therapy and whole body vibration exercises

    Other: Conventional physical therapy

Interventions

  • OtherConventional physical therapy

    * Standing with feet together while the therapist was sitting behind and manually locking the child knees. * Step standing with the therapist behind the child. * High step standing and trying to keep balanced. The child stood on exercise mattress. * Single leg stance "unilateral standing" with assistance. The child was standing on exercise mattress. * Standing on a declined surface by using wedge. The child was standing on wedge towards the descending direction. * Standing with manual locking of the knees. * Changing position. * Gait training. * Static and dynamic muscle contraction.

    Also known as: Physical therapy program

06

What researchers measure

Primary outcomes

  1. Biodex Balance System

    it is a reliable and objective assessment in order to quantify dynamic balance

    Time frame: before intervention and after 12 weeks of intervention

Secondary outcomes

  1. Hand-held dynamometer

    It is a portable device (Nicholas Manual Muscle Tester, Model 01160; Lafayette Instrument, Lafayette, IN), characterized as low-cost and convenient method

    Time frame: before intervention and after 12 weeks of intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2023; primary completion for Jan 2024, 3 months later.

Of 163 non-industry interventional studies with no phase under Down Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 33. This study's planned 3 months is below that.

Counting every sponsor, half of 165 studies reached it within 11 months; a quarter within 3 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2023
First posted
Sep 13, 2023
StartEst.
Oct 15, 2023
Primary completionEst.
Jan 15, 2024
CompletionEst.
Jan 20, 2024
Last update
Oct 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06036069
Lead sponsor
Ragaee Saeed Mahmoud
Responsible party
Ragaee Saeed Mahmoud (Lecturer, South Valley University) — Sponsor-investigator
First posted
Sep 13, 2023
Start date
Oct 15, 2023 (estimated)
Primary completion
Jan 15, 2024 (estimated)
Completion
Jan 20, 2024 (estimated)
Last update
Oct 13, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion